---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-011242"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2023-04-06T23:59:59+00:00"
generated_at: "2026-06-17T05:14:15.180348+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# AgeX draws remaining $1M under secured note; issues warrants for 756K shares

## Summary
- Drew $1M from Juvenescence under Amended and Restated Secured Convertible Promissory Note dated Feb 9, 2023.
- Repayment date for outstanding principal is February 14, 2024.
- Issued warrants to purchase 756,429 shares of common stock at $0.661 per share.
- Warrants issued in connection with the drawdown; exercise price based on March 30, 2023 closing price.

## SEC filing metadata
- accession: 0001493152-23-011242
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2023-04-06T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000149315223011242/0001493152-23-011242-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000149315223011242/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-011242
- JSON: https://secwatch.observer/filing/0001493152-23-011242.json
- Plain text: https://secwatch.observer/filing/0001493152-23-011242.txt

## Key facts
- Debt Financings
  Serina Therapeutics, Inc. incurred convertible notes of $1 million with Juvenescence Limited maturing February 14, 2024.
  - Instrument: convertible notes
  - Principal: $1 million
  - Counterparty: Juvenescence Limited
  - Maturity: February 14, 2024
  - Event: incurrence
  source text: On April 4, 2023, AgeX drew the remaining $1 million of its credit available under the Amended and Restated Secured Convertible Promissory Note (“Secured Note”) dated February 9, 2023 with Juvenescence Limited (“Juvenescence”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708599/000149315223011242/0001493152-23-011242-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
